RRM2 Enhances MYCN-Driven Neuroblastoma Formation and Acts as a Synergistic Target With CHK1 Inhibition

Researchers identified ribonucleotide reductase subunit M2 (RRM2) as a candidate dependency factor further supported by growth inhibition upon in vitro knockdown.